{name}
{subtitle}
Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) Plus Chemotherapy in Participants With Metastatic Esophageal Carcinoma (MK-7902-014/E7080-G000-320/LEAP-014)
city
~47 mi. (Guatel, Guatemala, +45 more cities)
facility
Centro Regional de Sub Especialidades Medicas SA ( Site 0604)
drug
cisplatin, +5 more drugs
drug type
chemotherapy, +2 more types
Efficacy and Safety of Olaparib (MK-7339) in Participants With Previously Treated, Homologous Recombination Repair Mutation (HRRm) or Homologous Recombination Deficiency (HRD) Positive Advanced Cancer (MK-7339-002 / LYNK-002)
city
~47 mi. (Guatel, Guatemala, +105 more cities)
facility
Centro Regional de Sub Especialidades Medicas SA ( Site 3003)
biomarker
ATM Loss, +62 more biomarkers
condition
Breast Carcinoma, +2 more conditions